tyrphostin a23 has been researched along with Urinary Bladder Neoplasms in 1 studies
tyrphostin A23: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyer, B | 1 |
| Thiery, JP | 1 |
1 other study available for tyrphostin a23 and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Cyclic AMP distinguishes between two functions of acidic FGF in a rat bladder carcinoma cell line.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Benzylidene Compounds; | 1993 |